Targeting Pharmacotherapy to Effectively Manage Eosinophilic Esophagitis
| Overview / Abstract: |
Two leading specialists in eosinophilic esophagitis (EoE) explore the increasing disease burden of this underrecognized cause of esophageal dysfunction that affects all age groups worldwide. A type-2 inflammatory condition, EoE is frequently characterized by allergic comorbidity but can also be misdiagnosed as the more common condition of gastroesophageal reflux disease. New and emerging treatments promise to improve outcomes for people with EoE. Drs. Mirna Chehade and Ikuo Hirano share best practices, as well as their own insights and clinical pearls based on their research and clinical practice with children and adults with EoE. This can lead to more expedient diagnosis, better adherence to treatment, and reduced disease burden. This interactive, case-based activity is designed for practicing clinicians. The faculty include lessons learned, quality-of-life considerations, and the near-term outlook for management of people with EoE. |
|
Expiration |
Mar 28, 2024 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
|
Format |
Webinar / Webcast / Video |
|
Credits / Hours |
1.5 |
|
Accreditation |
ACCME, ANCC, CA-BRN |
|
Presenters / Authors / Faculty |
Mirna Chehade, MD, MPH Ikuo Hirano, MD |
|
Sponsors / Supporters / Grant Providers |
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi. |
|
Keywords / Search Terms |
Annenberg Center for Health Sciences at Eisenhower Epidemiology, Pathogenesis, Burden of Disease, Clinical Features Diagnosis, Treatment, Patient Resources Free CE CME |
|